Physician profile

Imran Ashraf Khan

Pulmonary Disease · New Port Richey, FL

NPI 1811054539

$7,661.57

in general payments reported to CMS, 2019-2025

32 companies · $1,895 in 2025

The $1,895 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,011.97
Education$177.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $1,751.70 2019-2025 Trelegy Ellipta, Nucala, Arexvy
Jazz Pharmaceuticals INC. $1,171.37 2019-2025 Xywav
Astrazeneca Pharmaceuticals LP $981.87 2019-2025 Fasenra, Breztri, Airsupra
Actelion Pharmaceuticals US, INC. $482.57 2019-2025 Opsumit, Uptravi
Boehringer Ingelheim Pharmaceuticals, INC. $436.75 2019-2025 Ofev, Jascayd
Insmed, INC. $278.29 2019-2025 Arikayce, Brinsupri
Amgen INC. $262.57 2019-2025 Tezspire
Mallinckrodt Hospital Products INC. $248.35 2023-2025 Acthar
Genzyme Corporation $230.95 2023-2025
Harmony Biosciences LLC $229.81 2024-2025
United Therapeutics Corporation $189.74 2019-2025 Tyvaso, Tyvaso
Grifols USA, LLC $170.00 2023-2025 Prolastin-C Liquid
Regeneron Healthcare Solutions, INC. $165.43 2024-2025 Dupixent
Ucb, INC. $125.00 2025 Bimzelx
Avadel Cns Pharmaceuticals, LLC $112.27 2024-2025 Lumryz
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $109.99 2021
Takeda Pharmaceuticals U.S.A., INC. $106.51 2020-2024 Glassia
Inspire Medical Systems, INC. $86.17 2023 Inspire
Baxter Healthcare $71.16 2023-2025 Hillrom - Vest System Model 105 Home Care
Inogen, INC. $59.98 2023-2025 Inogen One G5 Oxygen Concentrator - Bluetooth
Merck Sharp & Dohme LLC $59.32 2023-2025 Winrevair
Novartis Pharmaceuticals Corporation $56.63 2019-2023
Verona Pharma, INC. $46.46 2025 Ohtuvayre
Phadia US INC. $43.44 2023-2024 Immunocap
Electromed, INC. $42.79 2019-2023 Smartvest
Philips North America LLC $33.78 2019-2020
Bayer Healthcare Pharmaceuticals INC. $21.45 2020
Mylan Specialty L.P. $19.82 2019
Resmed Corp $17.70 2025
Genentech USA, INC. $17.19 2019
Lilly USA, LLC $16.30 2025 Zepbound
3b Medical, INC. $16.21 2023 Luna

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Imran Ashraf Khan

$7,661.57

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $1,895 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/354961/imran-ashraf-khan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.